Company Profile
CEO
Dr. Albert Bourla D.V.M., Ph.D.(Chairman of the Board & CEO)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75.0K
Beta
0.29
Forward P/E
9.2
52W High
$28.75
52W Low
$23.08
Profit Margin
11.8%
Operating Margin
31.6%
Return on Equity
8.3%
Revenue Growth
5.4%
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic dise...
Valuation
Market Cap$145.96B
P/E (TTM)19.58
P/S (TTM)2.53
EV/EBITDA--
Cash Flow
FCF Yield+6.0%
SBC Adj. FCF Yield+5.2%
SBC Impact12.5%
Margins & Growth
Profit Margin18.6%
Operating Margin--
Revenue YoY5.4%
Earnings YoY-9.4%
Balance
Cash$1.76B
Debt$60.56B
Net Cash$-58.80B
Dividend
Dividend Yield6.70%
Payout Ratio91.0%
Quarterly Payout$2.44B